本页面由Tiger Trade Technology Pte. Ltd.提供服务

Karyopharm Therapeutics Inc.

0.5051
-0.0999-16.51%
盘后:0.51000.0049+0.97%19:30 EDT
成交量:89.86万
成交额:48.26万
市值:1,144.71万
市盈率:-0.04
高:0.6047
开:0.5937
低:0.5020
收:0.6050
52周最高:10.99
52周最低:0.5020
股本:2,266.29万
流通股本:1,729.27万
量比:0.78
换手率:5.20%
股息:- -
股息率:- -
每股收益(TTM):-13.0816
每股收益(LYR):-17.9300
净资产收益率:-891.05%
总资产收益率:-47.61%
市净率:-0.03
市盈率(LYR):-0.03

数据加载中...

2021/11/03

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/08/05

重要事件披露

8-K - Current report
2021/08/05

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/08/05

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2021/06/24

重要事件披露

8-K - Current report
2021/05/24

重要事件披露

8-K - Current report
2021/05/04

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/05/03

重要事件披露

8-K - Current report
2021/05/03

重要事件披露

8-K - Current report
2021/02/24

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2021/02/24

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/02/17

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/12

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/11

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/11

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/11

重要事件披露

8-K - Current report